Target Price | $172.94 |
Price | $165.21 |
Potential | 4.68% |
Number of Estimates | 25 |
25 Analysts have issued a price target Procter & Gamble 2025 . The average Procter & Gamble target price is $172.94. This is 4.68% higher than the current stock price. The highest price target is $187.00 13.19% , the lowest is $156.00 5.57% . | |
A rating was issued by 28 analysts: 19 Analysts recommend Procter & Gamble to buy, 8 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2025 of 4.68% . Most analysts recommend the Procter & Gamble stock at Purchase. |
24 Analysts have issued a sales forecast Procter & Gamble 2024 . The average Procter & Gamble sales estimate is $84.3b . This is 0.33% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $84.6b 0.66% , the lowest is $84.0b 0.03% .
This results in the following potential growth metrics:
2023 | $82.0b | 2.27% |
---|---|---|
2024 | $84.3b | 2.84% |
2025 | $87.2b | 3.36% |
2026 | $89.7b | 2.96% |
2027 | $94.5b | 5.33% |
2028 | $97.5b | 3.18% |
23 Analysts have issued an Procter & Gamble EBITDA forecast 2024. The average Procter & Gamble EBITDA estimate is $23.0b . This is 0.40% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $23.3b 1.09% , the lowest is $21.5b 6.99% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $21.1b | 1.69% |
---|---|---|
2024 | $23.0b | 9.10% |
2025 | $24.6b | 6.95% |
2026 | $26.2b | 6.59% |
2027 | $27.5b | 5.07% |
2028 | $29.5b | 6.99% |
2023 | 25.69% | 0.56% |
---|---|---|
2024 | 27.26% | 6.09% |
2025 | 28.20% | 3.45% |
2026 | 29.20% | 3.55% |
2027 | 29.13% | 0.24% |
2028 | 30.20% | 3.67% |
13 Procter & Gamble Analysts have issued a net profit forecast 2024. The average Procter & Gamble net profit estimate is $14.8b . This is 2.28% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $15.7b 8.66% , the lowest is $14.0b 3.10% .
This results in the following potential growth metrics and future Net Margins:
2023 | $13.9b | 1.55% |
---|---|---|
2024 | $14.8b | 6.09% |
2025 | $16.4b | 10.73% |
2026 | $17.6b | 7.39% |
2027 | $18.6b | 5.93% |
2028 | $19.5b | 4.62% |
2023 | 16.98% | 0.70% |
---|---|---|
2024 | 17.52% | 3.18% |
2025 | 18.77% | 7.13% |
2026 | 19.58% | 4.32% |
2027 | 19.69% | 0.56% |
2028 | 19.96% | 1.37% |
13 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble <a href=/blog/eps>EPS is $6.26 . This is 2.29% higher than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is $6.65 8.66% , the lowest is $5.93 3.10% .
This results in the following potential growth metrics and future valuations:
2023 | $5.90 | 1.55% |
---|---|---|
2024 | $6.26 | 6.10% |
2025 | $6.93 | 10.70% |
2026 | $7.44 | 7.36% |
2027 | $7.89 | 6.05% |
2028 | $8.25 | 4.56% |
Current | 27.01 | 1.39% |
---|---|---|
2024 | 26.39 | 2.30% |
2025 | 23.84 | 9.66% |
2026 | 22.19 | 6.92% |
2027 | 20.95 | 5.59% |
2028 | 20.03 | 4.39% |
Based on analysts' sales estimates for 2024, the Procter & Gamble stock is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of 4.93 and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of 4.62 .
This results in the following potential growth metrics and future valuations:
Current | 4.95 | 3.34% |
---|---|---|
2024 | 4.93 | 0.31% |
2025 | 4.77 | 3.25% |
2026 | 4.64 | 2.87% |
2027 | 4.40 | 5.07% |
2028 | 4.27 | 3.08% |
Current | 4.64 | 5.01% |
---|---|---|
2024 | 4.62 | 0.33% |
2025 | 4.47 | 3.25% |
2026 | 4.34 | 2.87% |
2027 | 4.12 | 5.06% |
2028 | 4.00 | 3.08% |
Procter & Gamble...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.